# Conjugated Estrogen

## Estromon 0.625mg

| TAH Drug Code      | [OEST6](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OEST6)                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | ‧ Vasomotor symptoms associated with menopause ‧ Atrophic vaginitis ‧ Osteoporosis ‧ Vulvar atrophy ‧ Female hypogonadism ‧ Primary ovarian insufficiency ‧ Dysfunctional uterine bleeding due to hormonal imbalance                                                                                                                                                                         |
| Dosing             | Continue administetion or cyclic administration (3 weeks on & 1 week off) should be used.Atrophic vaginitis and atrophic urethritis caused by lack of estrogen: 0.3-1.25mg daily. Osteoporosis: 0.625mg daily. Protection of the cardiovascular system: 0.625-1.25mg daily. Low of feminine estrogen: 0.3-1.25mg daily. Promote the development of secondary sexual characteristics: 0.15mg. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Malignant neoplastic disease of the breast or genital tract (unless indicated for the treatment of the neoplasm); previous thromboembolic disorders, CV disease, thrombophlebitis; undiagnosed vag bleeding; liver impairment; pregnancy.                                                                                                                                                    |
| Adverse Effects    | Fluid & salt retention, edema; weight gain; breast tenderness, gynecomastia; altered liver function, jaundice; depression; GI upsets, dizziness, chloasma, rash, urticaria, erythema multiforme; endometrial hyperplasia.                                                                                                                                                                    |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/estradiol-drug-information)                                                                                                                                                                                                                                                                                                                     |

